Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Theillet

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Oncotarget|January 2, 2018
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortiumEva Obermayr, Natalia Bednarz-Knoll, Beatrice Orsetti, et al.
International Journal of Cancer|July 19, 2002
Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomasEvgeny N Imyanitov, Evgeny N Suspitsin, Maxim Yu Grigoriev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2016
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and MetastasisWilhem Leconet, Myriam Chentouf, Stanislas du Manoir, et al.
Genes, Chromosomes & Cancer|September 28, 2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT geneCornel Popovici, Céline Basset, François Bertucci, et al.
Nature Communications|September 22, 2020
A predictable conserved DNA base composition signature defines human core DNA replication originsIldem Akerman, Bahar Kasaai, Alina Bazarova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management CareSafia El Messaoudi, Florent Mouliere, Stanislas Du Manoir, et al.
International Journal of Cancer|March 19, 2019
An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancerLaura Bourillon, Céline Bourgier, Nadège Gaborit, et al.
Oncotarget|December 10, 2017
Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibitionStéphanie Arnould, Geneviève Rodier, Gisèle Matar, et al.
Nature Communications|February 23, 2016
TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasionClément Chevalier, Guillaume Collin, Simon Descamps, et al.
Genes, Chromosomes & Cancer|June 12, 2003
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 geneJosé Adélaïde, Huai-En Huang, Anne Murati, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Oncotarget|January 2, 2018
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortiumEva Obermayr, Natalia Bednarz-Knoll, Beatrice Orsetti, et al.
International Journal of Cancer|July 19, 2002
Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomasEvgeny N Imyanitov, Evgeny N Suspitsin, Maxim Yu Grigoriev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2016
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and MetastasisWilhem Leconet, Myriam Chentouf, Stanislas du Manoir, et al.
Genes, Chromosomes & Cancer|September 28, 2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT geneCornel Popovici, Céline Basset, François Bertucci, et al.
Nature Communications|September 22, 2020
A predictable conserved DNA base composition signature defines human core DNA replication originsIldem Akerman, Bahar Kasaai, Alina Bazarova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management CareSafia El Messaoudi, Florent Mouliere, Stanislas Du Manoir, et al.
International Journal of Cancer|March 19, 2019
An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancerLaura Bourillon, Céline Bourgier, Nadège Gaborit, et al.
Oncotarget|December 10, 2017
Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibitionStéphanie Arnould, Geneviève Rodier, Gisèle Matar, et al.
Nature Communications|February 23, 2016
TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasionClément Chevalier, Guillaume Collin, Simon Descamps, et al.
Genes, Chromosomes & Cancer|June 12, 2003
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 geneJosé Adélaïde, Huai-En Huang, Anne Murati, et al.
Pageof 6